Department of Biomedical and Nutritional Sciences, University of Massachusetts Lowell, Lowell, MA, USA.
Center for Population Health, University of Massachusetts Lowell, Lowell, MA, USA.
J Bone Miner Res. 2021 Oct;36(10):1881-1905. doi: 10.1002/jbmr.4417. Epub 2021 Oct 7.
Osteoporosis is a bone disease classified by deterioration of bone microarchitecture and decreased bone strength, thereby increasing subsequent risk of fracture. In the United States, approximately 54 million adults aged 50 years and older have osteoporosis or are at risk due to low bone mass. Osteoporosis has long been viewed as a chronic health condition affecting primarily non-Hispanic white (NHW) women; however, emerging evidence indicates racial and ethnic disparities in bone outcomes and osteoporosis management. The primary objective of this review is to describe disparities in bone mineral density (BMD), prevalence of osteoporosis and fracture, as well as in screening and treatment of osteoporosis among non-Hispanic black (NHB), Hispanic, and Asian adults compared with NHW adults living on the US mainland. The following areas were reviewed: BMD, osteoporosis prevalence, fracture prevalence and incidence, postfracture outcomes, DXA screening, and osteoporosis treatments. Although there are limited studies on bone and fracture outcomes within Asian and Hispanic populations, findings suggest that there are differences in bone outcomes across NHW, NHB, Asian, and Hispanic populations. Further, NHB, Asian, and Hispanic populations may experience suboptimal osteoporosis management and postfracture care, although additional population-based studies are needed. There is also evidence that variation in BMD and osteoporosis exists within major racial and ethnic groups, highlighting the need for research in individual groups by origin or background. Although there is a clear need to prioritize future quantitative and qualitative research in these populations, initial strategies for addressing bone health disparities are discussed. © 2021 American Society for Bone and Mineral Research (ASBMR).
骨质疏松症是一种骨骼疾病,其特征为骨微观结构恶化和骨强度降低,从而增加随后骨折的风险。在美国,约有 5400 万 50 岁及以上的成年人患有骨质疏松症或因骨量低而有患病风险。长期以来,骨质疏松症一直被视为一种主要影响非西班牙裔白人(NHW)女性的慢性健康状况;然而,新出现的证据表明,在骨骼结局和骨质疏松症管理方面存在种族和民族差异。本综述的主要目的是描述与居住在美国大陆的非西班牙裔白人(NHW)成年人相比,非西班牙裔黑人(NHB)、西班牙裔和亚裔成年人在骨矿物质密度(BMD)、骨质疏松症和骨折的患病率、以及骨质疏松症筛查和治疗方面的差异。综述的领域包括:BMD、骨质疏松症的患病率、骨折的患病率和发生率、骨折后的结局、DXA 筛查和骨质疏松症的治疗。尽管在亚洲和西班牙裔人群中关于骨骼和骨折结局的研究有限,但研究结果表明,NHW、NHB、亚洲和西班牙裔人群的骨骼结局存在差异。此外,尽管需要进行更多的基于人群的研究,但 NHB、亚洲和西班牙裔人群可能经历着不理想的骨质疏松症管理和骨折后的护理。此外,还有证据表明,主要种族和族裔群体内部的 BMD 和骨质疏松症存在差异,这凸显了按原籍或背景对个别群体进行研究的必要性。尽管明确需要优先对这些人群进行未来的定量和定性研究,但仍讨论了处理骨骼健康差异的初始策略。© 2021 美国骨骼与矿物质研究协会(ASBMR)。